MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers-Reference-Cited by-同舟云学术

MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers

Published:2011-03 Issue:7338 Volume:471 Page:377-381
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Steidl Christian,Shah Sohrab P.,Woolcock Bruce W.,Rui Lixin,Kawahara Masahiro,Farinha Pedro,Johnson Nathalie A.,Zhao Yongjun,Telenius Adele,Neriah Susana Ben,McPherson Andrew,Meissner Barbara,Okoye Ujunwa C.,Diepstra Arjan,van den Berg Anke,Sun Mark,Leung Gillian,Jones Steven J.,Connors Joseph M.,Huntsman David G.,Savage Kerry J.,Rimsza Lisa M.,Horsman Douglas E.,Staudt Louis M.,Steidl Ulrich,Marra Marco A.,Gascoyne Randy D.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature09754.pdf

Reference41 articles.

1. Dyer, M. J. The pathogenetic role of oncogenes deregulated by chromosomal translocation in B-cell malignancies. Int. J. Hematol. 77, 315–320 (2003)

2. Kerckaert, J. P. et al. LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas. Nature Genet. 5, 66–70 (1993)

3. Blank, C., Gajewski, T. F. & Mackensen, A. Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy. Cancer Immunol. Immunother. 54, 307–314 (2005)

4. Rimsza, L. M. et al. Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project. Blood 103, 4251–4258 (2004)

5. Martin-Subero, J. I. et al. Chromosomal breakpoints affecting immunoglobulin loci are recurrent in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma. Cancer Res. 66, 10332–10338 (2006)

Cited by 530 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A one-way street recognition approach to mediate allogeneic immune cell therapies;Cell Stem Cell;2024-09

2. Intra‐tumoral and peripheral blood TIGIT and PD‐1 as immune biomarkers in nodular lymphocyte predominant Hodgkin lymphoma;American Journal of Hematology;2024-08-17

3. IRF8-mutant B cell lymphoma evades immunity through a CD74-dependent deregulation of antigen processing and presentation in MHCII complexes;Science Advances;2024-07-12

4. Multimodal integration of clinic, pathology, and genomics for a rare diagnosis of EBV-positive primary mediastinal large B-cell lymphoma;Virchows Archiv;2024-06-04

5. The biology of classical Hodgkin lymphoma;Seminars in Hematology;2024-05